AbTarget™ delivers high quality, validated monoclonal antibodies against a large number (but unspecified) of proteins in a cell, organ, tissue, organelle or any complex protein sample.
AbTarget™ is a fit-for-purpose, reverse antibody methodology by generating proteome-scale antibody libraries first, isolation and target identification second. This approach has been proven to be highly effective in yielding applications (WB/IF/flow cytometry/IP) validated antibodies at a proteome-scale.
AbTarget™ is based on MabArray™ antibody array technology, a massively parallel, proprietary antibody array platform with close to 50,000 pre-made monoclonal antibodies. MabArray™ represents a fundamental breakthrough by solving the long-standing “content” problem of antibody array technology.